This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Pharmacological properties

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Like the phenothiazines the tricyclics have widespread actions on the nervous system and therefore have a large number of potential side effects. It used to be believed that their common antidepressant effect was due to inhibition of re-uptake at central monoamine synapses with a subsequent increased transmitter concentration at receptor sites. However, the time of onset of anti-depressant effect does not correlate with that inhibition of reuptake, and some newer antidepressants are not potent inhibitors of reuptake. It now seems likely that they act by a secondary alteration in post synaptic receptor sensitivity and monoamine transmission.

Some tricyclic compounds are strongly anticholinergic, and have many side effects related to this, or strongly antihistaminergic or both. Most are less strongly antiserotoninergic and antiemetic (antidopamine) than chlorpromazine.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.